The global single cell analysis system market was valued at USD 3.2 Billion in 2022 and is expected to reach USD 7.2 Billion by 2033. The automated cell analysis system has topped the global market in 2022 with a market share of 42.0% and is expected to grow at a CAGR of 7.8% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 3.2 Billion |
| Market Value 2023 | USD 3.4 Billion |
| Market Value 2033 | USD 7.2 Billion |
| CAGR 2023–2033 | 7.8% |
| Market Share of Top 5 Countries | 63.40% |
| Key Market Players | 10x Genomics; Fluidigm Corporation; Bio-Rad Laboratories; Illumina; Takara Bio; Agilent Technologies; Mission Bio; NanoString Technologies; Thermo Fisher Scientific; Miltenyi Biotec GmbH; BGI Group; Genotypic Technology Pvt. Ltd.; SciGenom Labs Pvt. Ltd., Pvt. |
A single cell analysis system is a valuable tool for examining individual cells and providing precise information about their distinct properties and behaviors. This type of study is particularly beneficial for gaining a better understanding of stem cell behavior, tumor growth, and various biological aspects related to cells.
Single-cell analysis enables in-depth investigation of molecular contents such as genomics, proteomics, transcriptomics, and metabolomics/fluxomics.
By employing mathematical and computer modeling, it is possible to explore cellular activities at multiple levels, from the genome to live organisms. This approach has proven effective in optimizing medical practices, studying cellular heterogeneity, investigating complex disorders like cancer, and comprehending metabolic processes and phenotypic variations at the cellular and subcellular levels.
Single-cell research also enhances our understanding of cellular responses to the environment and intracellular interactions, with significant implications for therapeutics and diagnostics.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global single cell analysis system market expanded at a CAGR of 6.8% over the last five years (2017 to 2022).
In 2022, the single cell analysis system market accounted for over 5.1% of the global cellular analysis market, valued at USD 6.2 Billion. The global market for automated cell culture systems is projected to experience significant growth, fueled by the increasing incidence of chronic diseases, rapid technological advancements, and the widespread use of cell culture techniques in various applications.
The advancement of single-cell analysis technologies serves as a key driver for this growth. These innovative methods have revolutionized the field of cell analysis by enabling researchers to study individual cells with unprecedented depth and accuracy.
They open up new possibilities for personalized treatments, drug development, and a better understanding of complex disorders. As the demand for more precise and efficient cell analysis methods continues to rise, the utilization of single-cell analysis systems is expected to play a crucial role in advancing our understanding of human health and driving medical breakthroughs.
The increasing research in fields like cancer and stem cell biology is a significant driver behind the growing demand for the single cell analysis system market. These fields heavily rely on single cell analysis to understand the intricate cellular mechanisms underlying diseases and to develop targeted therapies.
Single cell analysis enables researchers to study individual cells with unprecedented precision, uncovering critical insights into cellular heterogeneity, rare cell populations, and drug responses. As the importance of personalized medicine and precision therapies continues to rise, the demand for single cell analysis systems is expected to further increase.
This trend emphasizes the pivotal role of single cell analysis in advancing our understanding of complex diseases and driving breakthroughs in treatment strategies.
Manufacturers in the single-cell analysis system market have the potential to design efficient analysis systems due to the availability of modern technologies such as flow cytometers, PCR, next-generation sequencing, and AI-driven software. These technologies enable advanced analysis of individual cells and provide valuable insights for various applications, particularly in cancer research and personalized therapy.
Manufacturers can focus on developing ways to distinguish between inter and intra-tumor variability in transcriptome profiles. This will help improve patient care by offering more accurate and personalized treatment choices based on genetic traits.
Additionally, collaborations between different technologies can enhance the capabilities of single-cell analysis systems. For instance, the integration of graph neural networks (GNN) and attention processes with AI-driven software can improve the efficacy and explainability of deep learning models.
GNN models can be utilized in single-cell analysis systems to enhance gene imputation, cell clustering, and disease-specific indicators, ultimately improving precision oncology and disease diagnosis.
Innovation and expansion can be further stimulated through partnerships and product launches.
For example, companies like Molecular Devices, LLC have released small and low-cost solutions, such as the SpectraMax® Mini Multi-Mode Microplate Reader, to meet the specific needs of researchers while conserving benchtop space and budget.
Overall, manufacturers in the single-cell analysis system market can leverage modern technologies and collaborative efforts to drive innovation, expand research capacity, and contribute to advances in precision medicine and personalized therapy. By capitalizing on these opportunities, they can further enhance the capabilities of their analytical systems and support crucial advancements in understanding human diseases, particularly cancer.
Principal Consultant
The high costs associated with single cell analysis systems act as a significant restraining factor for their widespread adoption and demand. These systems involve substantial upfront investment, including the purchase of specialized equipment, consumables, and software.
The cost can be a barrier for smaller research institutions, laboratories, or facilities with limited budgets. Additionally, the ongoing expenses related to maintenance, upgrades, and consumables can further strain the financial resources.
The high costs of these systems limit their accessibility and hinder their adoption, particularly in resource-constrained settings. Finding ways to reduce the costs or offer cost-effective alternatives will be essential in expanding the market and promoting wider utilization of single cell analysis systems.
Sample heterogeneity represents a significant factor restraining the demand for single cell analysis systems. The presence of diverse cell types and characteristics within samples can pose challenges in accurately isolating and analyzing specific cells of interest. The complexity of handling and interpreting heterogeneous samples can require specialized techniques and expertise, limiting the accessibility and ease of use of single cell analysis systems.
The USA is a prominent market for single cell analysis systems in the North America and accounts for 93.2% market share in 2022, due to its strong research and innovation ecosystem and the availability of substantial funding and investment support.
The country's robust infrastructure of academic and research institutions, pharmaceutical companies, and biotech startups creates a thriving environment for the development and adoption of advanced technologies like single cell analysis systems. The presence of prestigious government agencies, such as the NIH and NSF, ensures significant funding for scientific research, driving the demand for cutting-edge tools and technologies.
Moreover, the active involvement of venture capital firms and private investors further stimulates innovation and growth in the market. Overall, the USA's research and funding landscape, combined with its large healthcare market, positions it as a prominent hub for the adoption and utilization of single cell analysis systems, paving the way for advancements in life sciences and healthcare research.
In 2022, Germany held a dominant share of the Europe market and contributed around USD 286.9 Million. The country has a robust research and development infrastructure with renowned academic institutions and leading pharmaceutical companies. Germany's strong emphasis on scientific innovation and advanced healthcare systems drives the demand for cutting-edge technologies like single-cell analysis systems.
Additionally, the government's support through funding programs and a favorable regulatory environment further propels the market. Germany's reputation for high-quality research and its thriving biotechnology sector makes it an attractive market for single cell analysis systems.
India holds a significant market share of 7.7% in the global cell analysis system market. India has a large and diverse population, providing a vast patient pool for medical research and diagnostics. Secondly, the country is witnessing a rising prevalence of chronic diseases, increasing the demand for advanced diagnostic tools like single cell analysis systems.
Lastly, India has a growing biotechnology and pharmaceutical sector, supported by government initiatives and investments, fostering research and development in the field of single cell analysis.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Receptor functional analysis accounts for 14.3% of the market share by application in the global market in 2022. Receptor functional analysis provides high-resolution and quantitative measurements of receptor activity at the single-cell level. This allows researchers to study receptor-ligand interactions, signal transduction pathways, and downstream cellular responses with exceptional sensitivity and specificity.
Single cell analysis enables the characterization of receptor heterogeneity within a cell population, identification of rare cell subsets, and investigation of dynamic changes in receptor function. These insights are crucial for understanding cellular processes, and disease mechanisms, and developing targeted therapies.
The automated cell analysis system is leading the system segment with a 42.0% market share in 2022. The Automated Cell Analysis System enables high-throughput analysis, providing a quick and efficient examination of numerous individual cells. It automates sample preparation, staining, imaging, and data processing, saving time and labor costs.
The system's modern imaging technologies, such as high-resolution microscopy and fluorescence imaging, visualize cellular architecture, biomarkers, and signaling events at the single-cell level, offering valuable insights into cellular processes and complex biological events.
Continuous research and development efforts ensure these systems stay at the forefront of technological advancements and meet the evolving demands of cell signalling research.
Consumables accounts for 49.3% of the global single cell analysis system market, valued at USD 1,572.1 million USD. They play a crucial role in ensuring accurate findings, technological advancements, and widespread adoption of single cell analysis across various research domains.
Consumables encompass reagents, kits, and supplies necessary for sample preparation, cell isolation, library preparation, and data analysis in single cell analysis systems.
These specialized consumables cater to the unique requirements of working with individual cells, supporting research in genomics, cancer, immunology, and neurology, among other fields. The growing demand for single cell analysis has fuelled the need for these consumables, which facilitate in-depth cellular investigations.
The Academic and Research Organisation (ARO) sector holds a significant position in the single cell analysis system market, accounting for 65.3% of end users and exhibiting a CAGR of 8.3% over the forecast period. Academic and research organisations are focused on advancing scientific knowledge through research and frequently engage in cutting-edge studies that necessitate advanced technologies like single cell analysis systems.
Given their emphasis on in-depth research and scientific discovery, AROs naturally utilize single cell analysis systems to investigate cellular heterogeneity and comprehend biological processes at the single cell level.
Additionally, adequate funding from government organizations, private foundations, and research funds enables AROs to invest in state-of-the-art research equipment, including single cell analysis devices, staying at the forefront of scientific discoveries.
Impedance-based analysis has emerged as a crucial technique in single cell analysis, accounting a market share of 26.9% in 2022 with a projected CAGR of 10.3% over the forecast period. Its attributes of precision, sensitivity, non-invasiveness, real-time monitoring, adaptability, and cost-effectiveness have made it indispensable in cell signalling research.
By enabling real-time and continuous assessment of cellular responses, it facilitates the detection of transient changes and temporal patterns in cellular behaviour, providing valuable insights into cellular processes.
Key players in the single cell analysis market, such as 10x Genomics and Illumina, focus on innovation, product development, strategic partnerships, and market expansion to maintain a competitive edge.
Similarly, recent developments related to the company’s manufacturing the single cell analysis system have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Nordics, Russia, India, Thailand, China, Indonesia, Malaysia, Phillipines, Singapore, Japan, South Korea, Australia, New Zealand, GCC countries, Northern Africa, Türkiye and South Africa. |
| Key Market Segments Covered | Product, System Type, Application, Technology, End User, and Region |
| Key Companies Profiled | 10x Genomics; Fluidigm Corporation; Bio-Rad Laboratories; Illumina; Takara Bio; Agilent Technologies; Mission Bio; NanoString Technologies; Thermo Fisher Scientific; Miltenyi Biotec GmbH; BGI Group; Genotypic Technology Pvt. Ltd.; SciGenom Labs Pvt. Ltd. |
| Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market is valued at USD 3.4 billion in 2023.
Increased research in disciplines such as cancer and stem cell biology drives the market.
The market is forecast to register a CAGR of 7.8% through 2033.
The global market size is estimated to reach USD 7.2 billion by 2033.
The market rose at a 6.8% CAGR from 2017 to 2022.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Product 9.1. Instruments 9.1.1. Flow Cytometers 9.1.2. Polymerase Chain Reaction 9.1.3. Mass Spectroscopy 9.1.4. Next Generation Sequencing Systems 9.1.5. High Content Screening Systems 9.1.6. Automated Cell Counters 9.1.7. Microscopes 9.1.8. Cell Microarrays 9.1.9. Hemocytometers 9.1.10. Others 9.2. Consumables 9.3. Softwares 10. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033, By System Type 10.1. Manual Single Cell Analysis System 10.2. Semi-Automated Cell Analysis System 10.3. Automated Cell Analysis System 11. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Application 11.1. Cell Viability and Proliferation 11.2. Apoptosis 11.3. Compound Mediated Cytotoxicity 11.4. Receptor Functional Analysis 11.5. Pathogen Detection 11.6. Viral studies 11.7. Gene expression 11.8. Stem Cell Monitoring 11.9. Angiogenesis 11.10. Immunocytochemistry 11.11. Cell Cycle Analysis 11.12. Drug Screening 11.13. System Monitoring 11.14. Other Applications 12. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Technology 12.1. Time-lapse microscopy 12.2. Fluorescence Microscopy 12.3. Confocal Microscopy 12.4. Total Internal Reflection Fluorescence (TIRF) Microscopy 12.5. Microfluidics-Based Systems 12.6. Impedance-Based Analysis 12.7. Biosensors and Fluorescent Probes 12.8. Others 13. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033, By End User 13.1. Hospitals and Diagnostic Laboratories 13.2. Pharma & Biopharmaceutical Companies 13.3. Academic and Research Organization 13.4. Contact Research Organization 14. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Region 14.1. North America 14.2. Latin America 14.3. Europe 14.4. East Asia 14.5. South Asia 14.6. Oceania 14.7. Middle East and Africa (MEA) 15. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 22. Market Structure Analysis 23. Competition Analysis 23.1. 10x Genomics 23.2. Fluidigm Corporation 23.3. Bio-Rad Laboratories 23.4. Illumina 23.5. Takara Bio 23.6. Agilent Technologies 23.7. Mission Bio 23.8. NanoString Technologies 23.9. Thermo Fisher Scientific 23.10. Miltenyi Biotec GmbH 23.11. BGI Group 23.12. Genotypic Technology Pvt. Ltd. 23.13. SciGenom Labs Pvt. Ltd. 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Single Cell Analysis System Market
